Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-06

Clinical Trial Update: FCHV-HTN Implementation Trial in Nepal [NA]

View source ↗

Summary

A clinical trial update announcing the FCHV-HTN Implementation Trial in Nepal for hypertension, sponsored by Yale University, which is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Yale University | Conditions: Hypertension | NA | Status: RECRUITING